Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ: VFF) (TSX: VFF) today announced its financial results for the first quarter ended March 31, 2022. All figures are in U.S. dollars unless otherwise indicated.
"The first quarter of 2022 once again demonstrated the strength and earnings power of both our Canadian and U.S. Cannabis businesses," said Michael DeGiglio, Chief Executive Officer, Village Farms International. "In what is a typically soft season for retail sales in Canada, both Pure Sunfarms and Rose gained share in their respective focus markets, and delivered a 14th consecutive quarter of positive adjusted EBITDA for Canadian Cannabis. Pure Sunfarms' products continue to resonate with consumers, as our continued focus on quality, innovation and new product launches strengthen what has become one of the most respected and trusted brands in the Canadian market. In Quebec, we estimate that Rose is now a top three Licensed Producer by sales following strong market share gains since retail launch early last year. Rose is well positioned to continue this momentum throughout 2022, further benefitting from the many opportunities for collaboration with Pure Sunfarms. With our Canadian Cannabis business continuing to grow sales and market share domestically, we look forward to capitalizing on Pure Sunfarms' recent EU GMP certification to commence exportation to international markets."
"Our U.S. Cannabis segment delivered a solid performance, highlighted by a strong gross margin and positive adjusted EBITDA contribution. The integration of Balanced Health into the Village Farms family is progressing very well and confirms our belief in both the potential within the existing cannabinoid business and the significant near- and long-term opportunities in both the low-THC and high-THC product categories."
"As our Cannabis operations continued to deliver strong growth and profitability, Village Farms Fresh (Produce) faced one of the most difficult macro environments in its history. Strong revenue growth was more than offset by the inflationary impact of freight, labor, fertilizer, packaging and other cost increases. An industry-wide supply imbalance limited the producer's ability to pass along pricing to customers. We are evaluating new initiatives, including marketing partnerships to build more scale, spread costs and diversify product offerings. However, even in the currently negative EBITDA environment, we maintain the highest conviction that our U.S. cultivation footprint is a powerhouse opportunity for legal recreational cannabis when we can participate."
Mr. DeGiglio concluded, "Consumer takeaway trends during the first quarter further validated our brand and cultivation strategies. We expect continued momentum throughout 2022 and beyond as each of our cannabis businesses continues to launch innovative new products that address evolving consumer demand. We remain focused on seizing opportunities to continue to deliver top-tier profitability and market share in the high-growth global cannabis market."
Canadian Cannabis (Pure Sunfarms and Rose LifeScience) Financial Summary for the Three Months Ended March 31, 2022 and March 31, 2021
(millions except % metrics) | Three Months Ended March 31, | ||||
2022 | 2021 | Change of C$ | |||
C$ | US$ | C$ | US$ | ||
Total Gross Sales | $40.7 | $32.1 | $30.8 | $24.3 | +32% |
Total Net Sales | $27.6 | $21.8 | $22.1 | $17.5 | +25% |
Total Cost of Sales 1 | $18.1 | $14.3 | $15.8 | $12.5 | +15% |
Gross Margin 1 | $9.5 | $7.5 | $6.3 | $5.0 | +50% |
Gross Margin % 1 | 34% | 34% | 29% | 29% | +17% |
SG&A | $8.8 | $6.9 | $5.0 | $4.0 | -75% |
Share-based compensation | $0.5 | $0.4 | $1.4 | $1.1 | +67% |
Net income (loss) | $1.3 | $1.0 | ($3.6) | ($2.8) | +135% |
Adjusted EBITDA 2 | $2.7 | $2.1 | $3.1 | $2.5 | -15% |
Adjusted EBITDA Margin 2 | 10% | 10% | 14% | 14% | -29% |
|
Three months ended | ||
Channel | 2022 | 2021 |
Retail, Flower | 67% | 71% |
Retail, Derivatives | 8% | 13% |
Wholesale, Flower and Trim | 25% | 16% |
1. Excludes Rose LifeScience commission-based revenue. |
U.S. Cannabis (Balanced Health Botanicals and VF Hemp)
*Based on OCS market data for the quarter ended March 31, 2022 and sales information provided by Buddi retail store data from over 300 retailers across Alberta and British Columbia as of March 31, 2022.
The Company's financial statements for the three months ended March 31, 2022, as well as the comparative periods for 2021, have been prepared and presented under United States Generally Accepted Accounting Principals ("GAAP"). Balanced Health was acquired on August 16, 2021 and their results are presented in the operations of our consolidated wholly-owned subsidiaries for the three months ended March 31, 2022. The Company acquired 70% of Rose LifeScience on November 15, 2021 and their results are presented in the operations of our consolidated wholly-owned subsidiaries and the minority interest is presented in Net Income (Loss) Attributable to Non-controlling Interests, Net of Tax for the three months ended March 31, 2022.
(In thousands of U.S. dollars, except per share amounts, and unless otherwise noted)
For the three months ended March 31, | ||||||||
2022 (3) | 2021 (3) | |||||||
Sales | $ | 70,156 | $ | 52,396 | ||||
Cost of sales | (60,252) | (50,089) | ||||||
Gross margin | 9,904 | 2,307 | ||||||
Selling, general and administrative expenses | (16,971) | (8,092) | ||||||
Share-based compensation | (964) | (1,998) | ||||||
Interest expense | (683) | (741) | ||||||
Interest income | 110 | 3 | ||||||
Foreign exchange gain (loss) | 319 | (504) | ||||||
Other expense, net | (8) | (69) | ||||||
Gain on disposal of assets | — | — | ||||||
Recovery of income taxes | 1,666 | 1,839 | ||||||
Loss from consolidated entities | (6,627) | (7,255) | ||||||
Less: net loss attributable to non-controlling interests, net of tax | 162 | — | ||||||
Loss from equity method investments | (52) | (127) | ||||||
Net loss attributable to Village Farms International Inc. | $ | (6,517) | $ | (7,382) | ||||
Adjusted EBITDA (4) | $ | (6,111) | $ | 404 | ||||
Basic loss per share | $ | (0.07) | $ | (0.10) | ||||
Diluted loss per share | $ | (0.07) | $ | (0.10) | ||||
3. For the three months ended March 31, 2022, Balanced Health's financial results are fully consolidated in the financial results of the Company. For the three months ended March 31, 2022, Village Farms' share of Rose LifeScience's financial results are fully consolidated in the financial results of the Company with the minority non-controlling interest presented in net loss attributable to non-controlling interests, net of tax. 4. Adjusted EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by GAAP. Therefore, Adjusted EBITDA may not be comparable to similar measures presented by other issuers. Management believes that Adjusted EBITDA is a useful supplemental measure in evaluating the performance of the Company because it excludes non-recurring and other items that do not reflect our business performance. Adjusted EBITDA includes the Company's 70% interest in Rose LifeScience since acquisition and 65% interest in VFH. |
We caution that our results of operations for the three months ended March 31, 2022 and 2021 may not be indicative of our future performance, particularly in light of the ongoing COVID-19 pandemic. We are currently unable to assess the ultimate impact of the COVID-19 pandemic on our business and our results of operations for future periods.
(In thousands of U.S. dollars, except per share amounts, and unless otherwise noted)
For the Three Months Ended March 31, 2022 | |||||||||||||||||||||||
VF Fresh | Cannabis- | Cannabis- | Clean | Corporate | Total | ||||||||||||||||||
Sales | $ | 41,349 | $ | 21,769 | $ | 7,043 | $ | (5) | $ | — | $ | 70,156 | |||||||||||
Cost of sales | (45,520) | (12,259) | (2,331) | (142) | — | (60,252) | |||||||||||||||||
Selling, general and administrative expenses | (3,140) | (6,933) | (4,296) | (32) | (2,570) | (16,971) | |||||||||||||||||
Share-based compensation | — | (367) | (95) | — | (502) | (964) | |||||||||||||||||
Other (expense) income, net | (30) | (746) | — | (6) | 520 | (262) | |||||||||||||||||
Recovery of (provision for) income taxes | 1,715 | (639) | — | — | 590 | 1,666 | |||||||||||||||||
(Loss) income from consolidated entities | (5,626) | 825 | 321 | (185) | (1,962) | (6,627) | |||||||||||||||||
Less: net loss attributable to non-controlling interests, net of tax | — | 162 | — | — | — | 162 | |||||||||||||||||
Loss from equity method investments | — | — | (52) | — | — | (52) | |||||||||||||||||
Net (loss) income | (5,626) | 987 | 269 | (185) | (1,962) | (6,517) | |||||||||||||||||
Adjusted EBITDA (6) | $ | (6,201) | $ | 2,104 | $ | 580 | $ | (59) | $ | (2,535) | $ | (6,111) | |||||||||||
Basic (loss) income per share | $ | (0.06) | $ | 0.01 | $ | 0.00 | $ | (0.00) | $ | (0.02) | $ | (0.07) | |||||||||||
Diluted (loss) income per share | $ | (0.06) | $ | 0.01 | $ | 0.00 | $ | (0.00) | $ | (0.02) | $ | (0.07) | |||||||||||
For the Three Months Ended March 31, 2021 | |||||||||||||||||||||||
VF Fresh | Cannabis- | Cannabis- | Clean | Corporate | Total | ||||||||||||||||||
Sales | $ | 34,867 | $ | 17,460 | $ | — | $ | 69 | $ | — | $ | 52,396 | |||||||||||
Cost of sales | (34,150) | (15,248) | — | (691) | — | (50,089) | |||||||||||||||||
Selling, general and administrative expenses | (2,551) | (3,966) | — | (32) | (1,543) | (8,092) | |||||||||||||||||
Share-based compensation | — | (1,094) | — | — | (904) | (1,998) | |||||||||||||||||
Other expense, net | (256) | (630) | — | (12) | (413) | (1,311) | |||||||||||||||||
Recovery of income taxes | 505 | 644 | — | — | 690 | 1,839 | |||||||||||||||||
Loss from consolidated entities | (1,585) | (2,834) | — | (666) | (2,170) | (7,255) | |||||||||||||||||
Less: net loss attributable to non-controlling interests, net of tax | — | — | — | — | — | — | |||||||||||||||||
Loss from equity method investments | — | — | (127) | — | — | (127) | |||||||||||||||||
Net loss | (1,585) | (2,834) | (127) | (666) | (2,170) | (7,382) | |||||||||||||||||
Adjusted EBITDA (6) | $ | (492) | $ | 2,534 | $ | (79) | $ | (16) | $ | (1,543) | $ | 404 | |||||||||||
Basic loss per share | $ | (0.02) | $ | (0.04) | $ | (0.00) | $ | (0.01) | $ | (0.03) | $ | (0.10) | |||||||||||
Diluted loss per share | $ | (0.02) | $ | (0.04) | $ | (0.00) | $ | (0.01) | $ | (0.03) | $ | (0.10) | |||||||||||
5. For the three months ended March 31, 2022, Balanced Health's financial results are fully consolidated in the financial results of the Company. For the three months ended March 31, 2022, Village Farms' share of Rose LifeScience's financial results are fully consolidated in the financial results of the Company with the minority non-controlling interest presented in net loss attributable to non-controlling interests, net of tax. 6. Adjusted EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by GAAP. Therefore, Adjusted EBITDA may not be comparable to similar measures presented by other issuers. Management believes that Adjusted EBITDA is a useful supplemental measure in evaluating the performance of the Company because it excludes non-recurring and other items that do not reflect our business performance. Adjusted EBITDA includes the Company's 70% interest in Rose LifeScience since acquisition and 65% interest in VFH. |
A detailed discussion of our consolidated and segment results can be found in the 10Q MD&A on the Village Farms website under Financial Reports (https://villagefarms.com/financial-reports/) within the Investors section.
The following table reflects a reconciliation of net income to Adjusted EBITDA, as presented by the Company:
For the three months ended March 31, | ||||||||
(in thousands of U.S. dollars) | 2022 (9) | 2021 (9) | ||||||
Net loss | $ | (6,517) | $ | (7,382) | ||||
Add: | ||||||||
Amortization | 2,702 | 3,412 | ||||||
Foreign currency exchange (gain) loss | (319) | 504 | ||||||
Interest expense, net | 573 | 738 | ||||||
Recovery of income taxes | (1,666) | (1,839) | ||||||
Share-based compensation | 964 | 1,998 | ||||||
Interest expense for JVs | 13 | 14 | ||||||
Amortization for JVs | 94 | 34 | ||||||
Foreign currency exchange loss for JVs | 29 | — | ||||||
Purchase price adjustment (10) | (2,050) | 2,925 | ||||||
Amortization of deferred financing | 66 | — | ||||||
Adjusted EBITDA (11) | $ | (6,111) | $ | 404 | ||||
Adjusted EBITDA for JVs (12) | $ | (25) | $ | (79) | ||||
Adjusted EBITDA excluding JVs | $ | (6,086) | $ | 483 | ||||
9. For the three months ended March 31, 2022 and March 31, 2021, Pure Sunfarms is fully consolidated in the financial results of the Company. For the period January 1, 2022 to March 31, 2022, Balanced Health is fully consolidated in the financial results of the Company. For the period January 1, 2022 to March 31, 2022, Village Farms' share of Rose LifeScience's financial results are fully consolidated in the financial results of the Company. 10. The purchase price adjustment reflects the non-cash accounting charge to cost of sales resulting from the revaluation of Pure Sunfarms' inventory to fair value at the acquisition date. 11. Adjusted EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by GAAP. Therefore, Adjusted EBITDA may not be comparable to similar measures presented by other issuers. Management believes that Adjusted EBITDA is a useful supplemental measure in evaluating the performance of the Company because it excludes non-recurring and other items that do not reflect our business performance. Adjusted EBITDA includes the 70% interest in Rose LifeScience since acquisition and 65% interest in VFH. 12. The Adjusted EBITDA for JVs consists of the VF Hemp Adjusted EBITDA for the three months ended March 31, 2022 and 2021.
|
This press release is intended to be read in conjunction with the Company's Consolidated Financial Statements ("Financial Statements") and Management's Discussion & Analysis ("MD&A") for the three months and year ended March 31, 2022 in the Company Form 10-Q, which will be filed on (www.sec.gov/edgar.shtml) and SEDAR (www.sedar.com) and will be available at www.villagefarms.com.
In March 2020, the World Health Organization declared the outbreak of the COVID-19 virus a global pandemic. This outbreak continues to cause major disruptions to businesses and markets worldwide as the virus continues to spread. Several countries as well as certain states and cities within the United States and Canada have enacted temporary closures of businesses, issued quarantine or shelter-in-place orders and taken other restrictive measures. In response to the COVID-19 pandemic, the Company implemented safety protocols and procedures to protect its employees, its subcontractors, and its customers. These protocols take into consideration guidance from state and local government agencies as well as the Centers for Disease Control and Prevention and other public health authorities.
As of May 9, 2022, all of the Company's operations are operating normally, however, the extent to which COVID-19 and the related global economic crisis affect the Company's business, results of operations and financial condition, will depend on future developments that are highly uncertain and cannot be predicted, including the scope and duration of the pandemic and any recovery period, future actions taken by governmental authorities, central banks and other third parties (including new financial regulation and other regulatory reform) in response to the pandemic, and the effects on our produce, clients, vendors and employees. Village Farms continues to service its customers amid uncertainty and disruption linked to COVID-19 and is actively managing its business to respond to the impact.
Village Farms' management team will host a conference call today, Monday, May 10, 2022, at 8:30 a.m. ET to discuss its financial results. Participants can access the conference call by telephone by dialing (416) 764-8659 or (888) 664-6392, or via the Internet at: https://bit.ly/3LwGlTM.
For those unable to participate in the conference call at the scheduled time, it will be archived for replay both by telephone and via the Internet beginning approximately one hour following completion of the call. To access the archived conference call by telephone, dial (416) 764-8677 or (888) 390-0541 and enter the passcode 334813 followed by the pound key. The telephone replay will be available until Monday, May 17, 2022 at midnight (ET). The conference call will also be archived on Village Farms' website at http://villagefarms.com/investor-relations/investor-calls.
Village Farms leverages decades of experience as a large-scale, Controlled Environment Agriculture-based, vertically integrated supplier for high-value, high-growth plant-based Consumer Packaged Goods opportunities, with a strong foundation as a leading fresh produce supplier to grocery and large-format retailers throughout the US and Canada, and new high-growth opportunities in the cannabis and CBD categories in North America and selected markets internationally.
In Canada, the Company's wholly-owned Canadian subsidiary, Pure Sunfarms, is one of the single largest cannabis operations in the world, the lowest-cost greenhouse producer and one of Canada's best-selling brands. The Company also owns 70% of Québec-based, Rose LifeScience, a leading third-party cannabis products commercialization expert in the Province of Québec.
In the US, wholly-owned Balanced Health Botanicals is one of the leading CBD brands and e-commerce platforms in the country. Subject to compliance with all applicable US federal and state laws and stock exchange rules, Village Farms plans to enter the US high-THC cannabis market via multiple strategies, leveraging one of the largest greenhouse operations in the country (more than 5.5 million square feet in West Texas), as well as the operational and product expertise gained through Pure Sunfarms' cannabis success in Canada.
Internationally, Village Farms is targeting selected, nascent, legal cannabis and CBD opportunities with significant medium- and long-term potential, with an initial focus on the Asia-Pacific region and Europe.
This Press Release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is subject to the safe harbor created by those sections. This Press Release also contains "forward-looking information" within the meaning of applicable Canadian securities law. We refer to such forward-looking statements and forward-looking information collectively as "forward-looking statements". Forward-looking statements may relate to the Company's future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, expansion plans, litigation, projected production, projected costs, capital expenditures, financial results, taxes, plans and objectives of or involving the Company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable industry or the cannabis industry are forward-looking statements. In some cases, forward-looking information can be identified by such terms as "outlook", "may", "might", "will", "could", "should", "would", "occur", "expect", "plan", "anticipate", "believe", "intend", "try", "estimate", "predict", "potential", "continue", "likely", "schedule", "objectives", or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. The forward-looking statements in this Press Release are subject to risks that may include, but are not limited to: our limited operating history, including that of Rose LifeScience Inc. ("Rose"), Balanced Health Botanicals, LLC ("Balanced Health"), Pure Sunfarms, Inc.("Pure Sunfarms") and our operations of growing hemp in the United States; the legal status of Pure Sunfarms, Rose and Balanced Health cannabis business; risks relating to the integration of Balanced Health and Rose into our cannabis business; risks relating to obtaining additional financing, including our dependence upon credit facilities; potential difficulties in achieving and/or maintaining profitability; variability of product pricing; risks inherent in the cannabis, hemp, CBD, cannabinoids, and agricultural businesses; market position, ability to leverage current business relationships for future business involving hemp and cannabinoids, the ability of Pure Sunfarms and Rose to cultivate and distribute cannabis in Canada; existing and new governmental regulations, including risks related to regulatory compliance and licenses (e.g., Pure Sunfarms ability to obtain licenses for its Delta 2 greenhouse facility as well as additional licenses under the Canadian act respecting cannabis to amend to the Controlled Drugs and Substances Act, the Criminal Code and other Acts, S.C. 2018, c. 16 (Canada) for its Delta 3 greenhouse facility), and changes in our regulatory requirements; risks relating to conversion of our greenhouses to cannabis production for Pure Sunfarms; risks related to rules and regulations at the U.S. federal (Food and Drug Administration and United States Department of Agriculture), state and municipal levels with respect to produce and hemp; retail consolidation, technological advances and other forms of competition; transportation disruptions; product liability and other potential litigation; retention of key executives; labor issues; uninsured and underinsured losses; vulnerability to rising energy costs; environmental, health and safety risks, foreign exchange exposure, risks associated with cross-border trade; difficulties in managing our growth; restrictive covenants under our credit facilities; natural catastrophes; the ongoing and developing COVID-19 pandemic; and tax risks.
The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. Although the forward-looking statements contained in this Press Release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company's control, that may cause the Company's or the industry's actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company's filings with securities regulators, including this Press Release. In particular, we caution you that our forward-looking statements are subject to the ongoing and developing circumstances related to the COVID-19 pandemic, which may have a material adverse effect on our business, operations and future financial results.
When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this Press Release relate only to events or information as of the date on which the statements are made in this Press Release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.
| Last Trade: | US$0.78 |
| Daily Change: | 0.01 1.30 |
| Daily Volume: | 266,678 |
| Market Cap: | US$87.150M |
November 07, 2024 August 12, 2024 August 08, 2024 | |
DevvStream provides upfront capital for sustainability projects in exchange for carbon credit rights. Through these rights, the company generates and manages carbon credits by utilizing the most technologically advanced...
CLICK TO LEARN MORE
GreenPower Motor designs, builds and distributes a full suite of high-floor and low-floor all-electric medium and heavy-duty vehicles, including transit buses, school buses, shuttles, cargo van, and a cab and chassis...
CLICK TO LEARN MORE
